Deltec Asset Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Deltec Asset Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-122,367	Closed	-$1.26M	–	192
2023 Q2	$1.26M	Buy	+122,367	New	+$1.25M	0.27%	76

Deltec Asset Management's DALS Position: Q3 2023 in Review

Deltec Asset Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 122,367 shares — an estimated $1.26M sold.

Deltec Asset Management first reported a position in DALS in Q2 2023 and held it in 1 quarter. The position peaked at $1.26M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Deltec Asset Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Deltec Asset Management sold 122,367 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $1.26M.
Deltec Asset Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Deltec Asset Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $1.26M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Deltec Asset Management's 13F filing for Q3 2023, filed 23 Oct 2023.